Jci_page_head_homepage_01 Jci_page_head_homepage_02
James L. Smart, Virginie Tolle, Malcolm J. Low
Published in Volume 116, Issue 2
J Clin Invest. 2006; 116(2):495–505 doi:10.1172/JCI25243
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 1
Transgenic rescue of pituitary POMC expression.

(A) Schematic of WT Pomc+, null Pomc, and pHalEx2* Tg alleles. A neomycin (Neo) selection cassette replaces exon 3 in the Pomc allele, and a 23-bp oligonucleotide (asterisk) is inserted in the 5′ untranslated region of exon 2 of the Tg allele. The arrow above exon 1 represents the transcriptional start site. PCR primer locations for genotyping of the Pomc+ (i and ii), Pomc (iii and iv), and Tg (v and vi) alleles are indicated by half-arrows. (B and C) ACTH immunoreactivity in the pituitary anterior lobe (AL), intermediate lobe (IL), and medial basal hypothalamus (MBH) from mice of the indicated genotypes. 3V, third ventricle. Scale bars: 300 μm (pituitary) and 100 μm (MBH). (D and E) Quantitation of αMSH content in the pituitary gland and MBH from male mice of the indicated genotypes (n = 4). *P < 0.01, **P < 0.001, and ***P < 0.0001 compared with Pomc+/+Tg+. (F) Basal diurnal corticosterone levels in 10- to 15-week-old male and female Pomc+/+Tg+ and Pomc–/–Tg+ mice.